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Abstract
Vaccine hesitancy is a public health issue of growing concern. Extensive pre-existing literature
offers several explanations and conflicting viewpoints regarding reluctance toward vaccinations.
However, minimal research has been done exploring the upstream social determinants driving
vaccine hesitancy. Utilizing academic and gray literature and interviews with experts in the field,
this study addresses this gap in knowledge with the research question: To what extent does
privilege impact vaccine hesitancy and resistance? Vaccine hesitancy appears globally and is
particularly concerning given the re-emergence of vaccine-preventable diseases (VPDs).
Additionally, due to inconsistent causes, vaccine hesitancy is difficult to combat. In referencing
the history of the anti-vaccination movement and clearly defining social determinants of health
(SDH), this study provides clear evidence that suggests a relationship between vaccine hesitancy
and privilege, defined as educational achievement and socio-economic status (SES).
Nevertheless, the association between the two is difficult to define given the dichotomous
presentation of both low and high privilege with increased vaccine hesitancy. Perhaps knowledge
of the relationship of vaccine reluctance with the two extremes of privilege can pave the way for
future research into the understanding of this phenomenon.
Keywords: vaccine hesitancy, privilege, education, income
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Introduction
Smallpox is the first – and only – successfully eradicated human disease. Public health
interventions and increased knowledge surrounding the variola virus (which causes smallpox)
largely contributed to this effort. Nevertheless, this major feat could not have been accomplished
without the successful development and implementation of a vaccine. In 1796, Edward Jenner
revolutionized medicine with his discovery of disease immunity following deliberate exposure.
Jenner was not the first individual to suggest inoculation, nor was he the first to demonstrate its
success. In fact, the earliest vaccination efforts are linked to ancient China. Nevertheless, due to
globalization and persistence, Jenner’s privately published booklet outlining these findings
ultimately aided in founding the field of immunology (Riedel, 2005).
Since Edward Jenner’s smallpox vaccine, numerous additional vaccinations have been
developed, tested, and refined to safely combat a plethora of pathogens. Most immunizations
have proven effective in largely preventing the development of a particular disease or ailment.
While no other human disease has been universally eliminated, vaccines have significantly
impacted public and global health, namely through their contribution to the reduction of
mortality rates for numerous diseases, such as polio. Nevertheless, no vaccine is without risk,
which may include side effects, adverse reactions, or incomplete immunity. As such, widespread
vaccine use, especially when mandated, has repeatedly been met with opposition.
The anti-vaccination movement, which pre-dated Edward Jenner’s smallpox vaccine,
demonstrates a general hesitancy toward vaccinations. During the late 18th century, the initial
controversy was often a reflection of general medical distrust, concerns about safety or
sanitation, and religious beliefs. The ideology gained support, eventually resulting in the
development of the Anti-Vaccination League in England in 1853. The movement has since
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extended beyond Europe and become a global phenomenon. In some instances, reduced
vaccination rates have resulted in large-scale disease outbreaks. For example, measles returned to
the United States in 2013 after its successful elimination in 2000 (“The Anti-Vaccination
Movement,” 2016). In 2019, the World Health Organization (WHO) identified vaccine hesitancy
as one of ten major threats to global health, particularly due to its correlation with a greater
prevalence of vaccine-preventable diseases (VPDs). While vaccine hesitancy is not the sole
reason for these increases, VPDs are resurging in countries that previously had few cases (Ten
Threats to Global Health in 2019, n.d.). The ongoing SARS CoV-2 pandemic has demonstrated
the contemporary controversy and sustained relevance regarding vaccine hesitancy.
The reasons behind vaccine hesitancy vary drastically. In some circumstances, opting out
of routine vaccinations is an uninformed or misguided decision. Media, particularly the internet
and social media platforms, can be a highly utilized resource for gaining information on vaccinerelated matters, despite uncertainty regarding its credibility. Furthermore, historical, political,
and socio-cultural contexts can influence an individual’s decision to vaccinate themselves or
their children. In other instances, mistrust in the medical system, religious beliefs, past
experiences, or political perspectives may stimulate vaccine hesitancy (Dubé et al., 2013). While
there are numerous deliberate causes behind the anti-vaccination movement, perhaps more
nuanced, unconscious factors, such as privilege, contribute to vaccine hesitancy.
The purpose of this paper is to explore the role that privilege plays in vaccine hesitancy
and subsequent adherence to public health and safety efforts. The primary research question is:
To what extent does privilege impact vaccine hesitancy and resistance? This report will clearly
define relevant terms, such as vaccine hesitancy, privilege, and social determinants of health
(SDH). In answering the primary research question, this report will also explore the history
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behind vaccinations and the onset of their resistance, potential solutions for increased opposition
to vaccinations, and counterarguments, including the portrayal of privilege as an unrelated
indicator of vaccine hesitancy.

Research Methodology
This qualitative study is the culmination and analysis of extensive research and two
formal interviews with experts knowledgeable in vaccinology and vaccine hesitancy. The data
for this research was collected to obtain knowledge and expertise regarding vaccine hesitancy
and its potential correlation to privilege. Furthermore, a literature review offered essential
background information regarding the history of vaccine hesitancy, SDH, and a definition of
privilege.
This study incorporates primary and secondary sources into the literature review and
analysis. The academic, peer-reviewed literature was obtained through online databases, such as
Google Scholar and the Vanderbilt University Library. Search terms regarding “vaccine
hesitancy” and “privilege” proved to be the most effective. The content of this literature ranged
from an overview of vaccine hesitancy and its potential correlation with various aspects of
privilege to specific geographic or socio-economic case studies. Gray literature was primarily
derived from organizations promoting vaccine education and administration.
Interviews were conducted with professionals well-versed in vaccine hesitancy. Several
leading experts in the topic matter were contacted as potential interviewees via email. Names and
contact information for potential interviewees were obtained through research and academic
articles. Contact was not limited to a particular global region due to the possibility of virtual
interviews. Interviewees were ultimately selected based on their availability. All interviews were
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conducted virtually, via Zoom, due to the geographic locations of the interviewees. Verbal
consent was obtained from all individuals participating in this study.
Given his career-long involvement in vaccine hesitancy, Dr. Robert Jacobson was
selected as an interviewee. He is the medical director of the Population Health Science Program
at Mayo Clinic’s Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
in Rochester, Minnesota. His current work focuses on interventions for vaccine delivery at a
population level. Dr. Jacobson’s research predominantly seeks to increase vaccine uptake,
specifically in the United States. One aspect of his research involves the specific rhetoric used in
vaccine recommendations and how it may impact adherence.
A second interview was conducted with Dr. Matthew Browne. Dr. Browne is a professor
of psychology at Central Queensland University in Australia. While much of his research focuses
on gambling and addiction, he is interested in why people believe the things they do. As such,
several of his academic publications and podcast episodes focus on drivers of vaccine hesitancy.
Much of the interview focused on his previous research evaluating the overlap of privilege with
vaccine hesitancy in specific Australian regions. Dr. Browne offered additional insight on
general trends of vaccine skepticism globally.
Ethical considerations were implemented throughout the duration of this study. Works
referenced in this paper were properly cited. Furthermore, this study obtained Human Subject
Review from the School for International Training’s Internal Review Board in Nyon,
Switzerland. Data collection and analysis were not permitted before the project was approved.
No children or vulnerable populations were included in this study. Interviewees were explicitly
presented with their rights including privacy, anonymity, and confidentiality. Matters regarding
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the approval of quotes and the destruction of any recordings and transcriptions were discussed.
There are no conflicts of interest to declare.
This study did pose some difficulties and limitations. One major difficulty was the nonresponse of potential interviewees. Given the contemporary relevance of this topic, particularly
considering the SARS-CoV-2 pandemic, relevant professionals who did reply had limited or no
availability for an interview. Subsequently, no professionals from Switzerland or Europe were
interviewed. However, the use of interviewees from different continents added dimension and
diversity to the study. Additionally, the information obtained from the few interviews was not
sufficient without the support of peer-reviewed literature and other secondary sources. Time was
a significant limitation for this project. This topic is extensive and growing in relevance. As such,
this study is non-exhaustive and simply serves as a review of available information and a starting
point for future research. Furthermore, available literature tends to present information regarding
vaccine hesitancy with a bias toward vaccinations. Additionally, both interviewees presented
clear pro-vaccinated sentiment, which is also evident in their research. As such, the presented
information may lack complete neutrality.

Literature Review
History of Vaccine Hesitancy and the Anti-Vaccination Movement
It is not uncommon to discover that a favorite public figure – celebrity, athlete, or
politician – is vaccine-hesitant. Despite the recent uptick in its popularity, anti-vaccination
sentiment preceded the development of modern immunizations. The first recorded onset of the
movement was in France in 1763. Gatti, an Italian doctor, introduced Parisians to inoculation.
However, due to improper adherence to quarantine measures, the health and safety of other
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community members were placed at risk. As such, the French Parliament banned further
inoculation in Paris. Despite these governmental actions, inoculation gained popularity and
eventually led to Edward Jenner’s smallpox vaccine in 1796. Following The Vaccination Act of
1853 in England, which mandated smallpox vaccination for all infants within three months of
birth, the Anti-Vaccination League developed. As those in opposition – and the Anti-Vaccination
League – spread across the globe, various demonstrations, court battles, and even angry mobs
sought to eliminate vaccine mandates. (“The Anti-Vaccination Movement,” 2016).
During the 20th century, the efficacy and safety of numerous vaccinations were
questioned. In 1955, the Cutter Laboratories in California inadvertently produced Salk polio
vaccine doses containing the live virus. This incident resulted in vaccine administration which
caused polio, as opposed to preventing the disease. As a result, many became wary of
immunizations allegedly containing an inactivated virus. Furthermore, a 1974 report from
London linked neurological conditions to the Diphtheria, Tetanus, and Pertussis (DTP) vaccine.
Subsequently, global DTP vaccination rates plummeted, while respective epidemics increased
(“The Anti-Vaccination Movement,” 2016). Andrew Wakefield’s 1998 article in The Lancet is
perhaps of the most well-known arguments against vaccinations – specifically the Measles,
Mumps, and Rubella (MMR) vaccine. Wakefield’s article falsified data to link the MMR vaccine
with autism (and gastroenterology disease). Although the study has been discredited, The Lancet
has retracted the article, and Wakefield’s medical license was revoked, this argument remains
prominent among those who are vaccine-hesitant (McClure et al., 2017).
Many contemporary concerns regarding vaccinations closely parallel those of initial
hesitancies, despite the refinement of immunizations and the introduction of new medical
technologies. The most prominent arguments include the necessity and safety of vaccines, the
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science behind them, and compulsory policies. Initial critics suggested that vaccines caused more
harm than they prevented. Due to successful vaccination campaigns, many lack contemporary
familiarity with VPDs. As such, the benefits of vaccines are muddled, while perils are evident
(M. Browne, personal communication, April 20, 2022). Therefore, the need for vaccines remains
contested. Furthermore, regulations mandating vaccination have consistently been met with
opposition. In the United States, one case made its way to the Supreme Court, the highest
legislative authority in the country. The 1905 Jacobson v. Massachusetts case upheld the
government’s jurisdiction in mandating vaccines (Schwartz, 2012). During the 2019 SARS-CoV2 outbreak, nearly 100 years later, attempts to mandate vaccination were resisted.
The movement against vaccinations appears to be straightforward; individuals opt to
vaccinate (themselves or their children), or they refuse to do so. However, vaccine hesitancy
functions on a continuum. While some refuse vaccinations altogether, a larger proportion of the
population expresses concerns or doubts, instead choosing to delay or omit specific vaccinations
(McClure et al., 2017). The population can generally be divided into four groups: vaccine
seeking, vaccine complacent, vaccine-hesitant, and vaccine-resistant. Those who are vaccine
seeking and resistant are the two extremes. Those who are vaccine complacent are not against
vaccinations, rather they seek them at their own convenience or with strong urging from
trustworthy sources. Individuals who are vaccine-hesitant are not actively against vaccines, nor
do they necessarily doubt science. Instead, they are ambivalent. Ultimately, vaccine seeking,
vaccine complacent, and vaccine-hesitant individuals comprise the vast majority of the
population (R. Jacobson, personal communication, April 26, 2022). For example, in the United
States, only 0.7% of children under three years of age were completely unvaccinated against any
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disease (R. M. Jacobson et al., 2015). As such, it is important to identify an explicit distinction
between those who are vaccine-hesitant and those who refuse vaccination in all its forms.
In 2012, the WHO’s Strategic Advisory Group of Experts on Immunization (SAGE)
Working Group on Vaccine Hesitancy (WG) was tasked with developing a definition for vaccine
hesitancy. After deliberation and refinement, the WG released the definition:
Vaccine hesitancy refers to delay in acceptance or refusal of vaccination despite
availability of vaccination services. Vaccine hesitancy is complex and context specific,
varying across time, place and vaccines. It is influenced by factors such as complacency,
convenience and confidence. (MacDonald, 2015)
The WG incorporated the “3 Cs” model into this definition, attempting to summarize the
overarching complexities of vaccine decision-making. While confidence demonstrates overall
trust in vaccines, those who create them, and those who promote them, complacency elicits
perceived risks associated with vaccination uptake and VPDs. Finally, convenience encompasses
a variety of factors. To a degree, convenience embodies the physical ability to obtain a
vaccination, including geographic, timeliness, and language constraints and barriers
(MacDonald, 2015). In the case of COVID-19, two additional “Cs” have been included in the
model: calculation and collective responsibility. Calculation elicits an individual’s engagement
in and consideration of research weighing all the benefits and risks. Collective responsibility
regards the willingness to protect others through vaccinating themselves (Robson, 2021). All five
of these factors (confidence, complacency, calculation, convenience, and collective
responsibility) are important determinants in an individual’s decision to vaccinate against any
disease.
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Communication is an additional consideration in defining vaccine hesitancy.
Technological advancements have made communication faster and more effective. While poor
communication may fail to provide adequate information about the health benefits of
vaccinations, the oversaturation of media may also lead to increased hesitancy. The initial spread
of the anti-vaccination movement was spread through face-to-face, verbal communication.
Nowadays, websites, blogs, and email lists quickly connect individuals and allow them to openly
share their experiences and theories. Furthermore, a multitude of resources, both factually correct
and those based on misinformation, are readily available through the internet and social media.
Subsequently, it has become difficult to distinguish between reputable and untrustworthy sources
(Schwartz, 2012).

Social Determinants of Health and Defining “Privilege”
SDH are the upstream, non-medical factors that ultimately impact health, functioning,
and quality of life. In simpler terms, SDH are the antecedents of the causes of health outcomes.
According to the WHO, “They are the conditions in which people are born, grow, work, live, and
age, and the wider set of forces and systems shaping the conditions of daily life,” (Social
Determinants of Health, n.d.). SDH differ from health determinants, such as governmental
policies, and biological or genetic factors. Some examples of SDH include income, education,
gender (in)equity, food (in)security, neighborhood conditions, and access to safe drinking water
(NEJM Catalyst, 2017). Though SDH do not necessarily seem connected to health, they are of
the most influential factors. Research has repeatedly revealed SDH to account for 30-55% of
health outcomes (Social Determinants of Health, n.d.).
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Beyond impacting health outcomes, SDH are also linked to health equity. The 2005-2008
WHO Global Commission on SDH was developed to identify and find solutions for SDH that
were negatively impacting countries with poor health outcomes. This commission viewed health
holistically, regarding the entire world, as opposed to focusing solely on the “Global North” or
“Global South.” The Global Commission on SDH explicitly states:
The poor health of the poor, the social gradient in health within countries, and the marked
health inequities between countries are caused by the unequal distribution of power,
income, goods, and services, globally and nationally, the consequent unfairness in the
immediate, visible circumstances of peoples lives … and their chances of leading a
flourishing life. (The Commission on Social Determinants of Health, 2008, p. 1)
This final report essentially reveals the various manners in which SDH can both positively and
negatively impact health. The positive associations between SDH and beneficial and detrimental
health outcomes create extensive inequity. For example, income is an important SDH. Those
with higher incomes are afforded a higher quality of care through entities, such as better
insurance coverage, access to the best practitioners, and increased out-of-pocket treatment
options. Furthermore, income directly impacts and enables other SDH. Individuals of higher
socioeconomic status (SES) are more likely to have access to adequate transportation, higher
quality education, and nutritious, well-balanced foods. These positive trends are a stark contrast
to the negative impact that SDH may have on overall health outcomes. An individual of lower
SES may live or work in an environment that is polluted, have few, if any, resources to invest in
healthy behaviors, such as exercise, or be unable to access annual physicals. Therefore, the
presence of SDH yields great inequity in health outcomes between those who are impacted
positively and negatively.
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For this specific study, privilege will be defined in terms of education and socioeconomic status (SES). Education and income (measured as SES) are two important and
interconnected SDH. Frequently, these determinants are closely linked, as education level and
quality of educational institutions tend to further advance an individual’s economic attainment.
For example, an individual with a university-level degree will typically reach a higher income
than one who did not obtain a high school diploma. Conversely, students of higher SES have
been demonstrated to have higher academic achievement. While there are exceptions, vast
research, and experimentation have confirmed this positive association (Broer et al., 2019).
Subsequently, the overlap between these two measures of privilege makes them ideal identifiers
of the potential correlation with vaccine hesitancy.

Analysis
Presence and Impact of Vaccine Hesitancy
Vaccine hesitancy appears across the globe without clear association with a specific race,
religion, or community. Nevertheless, it poses a threat to the overall public and global health
(Dubé et al., 2014). Vaccine hesitancy – which often predicts under- and delayed childhood
vaccination – is a complicated behavior that can be influenced by a variety of highly variable
determinants. Despite extensive research conducted on the topic, there is no singular factor that
uniformly influences vaccine hesitancy across global populations (Larson et al., 2014).
Figure 1 graphs the child vaccination rates for DTP and measles across 44 countries. The
included countries represent all continents (excluding Antarctica) and a variety of developmental
stages and wealth ranges. Only one of the 44 countries (Hungary) has obtained a universal rate of
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vaccination. Deviation from complete coverage can be caused by numerous factors, including
vaccine hesitancy (OECD, 2022).

Figure 1. Child vaccination rates for DTP and Measles in 44 countries from 2018 or the latest available (OECD, 2022).

As evident in Figure 2, Europe’s sentiment toward vaccine safety is relatively negative.
France and Bosnia & Herzegovina are two countries disagreeing most with sentiments regarding
vaccine safety. A 2016 survey among over 65,000 individuals in 67 countries revealed that 41%
and 36% of respondents from France and Bosnia & Herzegovina, respectively, responded
negatively to vaccine-safety-related sentiment. The prevalence of these responses is particularly
stark when compared with the global average of 13%. Nevertheless, vaccines are widely
available and accessible in many European countries. The high hesitancy in the region does not
enforce the ideology that low vaccination uptake corresponds to insufficient or inadequate
resources (Larson et al., 2016).
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Figure 2. Global response "tend to disagree" or "strongly disagree" responses to the statement "Overall I think vaccines are
safe" (Larson et al., 2016).

Vaccine-hesitant individuals are protected, to a degree, by herd immunity, which is
developed through adherence to vaccination recommendations. Herd immunity occurs when a
large percentage of a population is protected against a specific pathogen. Individual protection
against VPDs typically includes three doses of DTP and one dose of the measles vaccine. Global
herd immunity against outbreaks of VPDs requires 95% coverage. However, as resistance to
vaccines persists, herd immunity becomes more difficult to attain, as the necessary level of
immunity is not being achieved. For example, since 2010 global vaccination coverage has
remained stagnant at approximately 86% and is not sufficient to create a global herd immunity
(20 Million Children Miss out on Lifesaving Measles, Diphtheria and Tetanus Vaccines in 2018,
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2019). Furthermore, in referencing Figure 1, many of the listed countries have not obtained herd
immunity, as one or both graphed vaccination rates are below 95%.
When individuals without a specific vaccination cluster together, a pocket of underimmunization is created. Subsequently, these areas are more likely to present with cases of VPDs
(R. M. Jacobson et al., 2015). Measles outbreaks can serve as an indicator of gaps in vaccination
due to the disease’s highly contagious nature. Complications associated with measles infection
include pneumonia, hearing loss, brain damage, and mortality (Malaysia: Addressing Vaccine
Hesitancy, 2016). When measles outbreaks occur in the world’s poorest countries, whose
inhabitants are at disproportionate marginalization and risk, the health outcomes are often the
most severe. Conversely, measles cases in privileged settings are not of the same concern, given
the accessibility and availability of lifesaving treatment and care (20 Million Children Miss out
on Lifesaving Measles, Diphtheria and Tetanus Vaccines in 2018, 2019). Therefore, since the
harmful effects of the measles (and other VPDs) are not perceived as threatening in these areas,
the necessity of vaccinations is less apparent (M. Browne, personal communication, April 20,
2022).

Case Study: Malaysia
As vaccine hesitancy increases, the greatest threat is the reintroduction of VPDs into
regions that have significantly limited or eliminated them. The national vaccination coverage for
young children has exceeded 90% in Malaysia. This achievement is largely due to the Malaysian
National Immunization Program, which provides vaccination against twelve major childhood
diseases in all government clinics and hospitals across the country, free of charge. Nevertheless,
between 2013 and 2018, measles cases in Malaysia rose 892% (from 195 to 1,934 cases). To an
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extent, the high measles prevalence can be attributed to an influx of migrants. However, the
measles cases among non-immunized individuals rose during this same period from 125 to 1467
cases, respectively (Wong et al., 2020). Furthermore, official reports reveal a drastic upsurge in
parents refusing vaccinations for their children. Between 2013 and 2015, the rate of vaccine nonacceptance rose by nearly 175%; from 470 to 1,292 children, respectively (Malaysia: Addressing
Vaccine Hesitancy, 2016).
In addition to the resurgence of VPDs, Malaysia is now struggling with the necessary
response to its subsequently impending crisis. Health professionals have attempted to identify
potential solutions without avail. Some advocate for compulsory vaccinations. However, critics
claim it would reinforce many of the sentiments that align with vaccine hesitancy. Data from
2016 attributed vaccine non-uptake to accessibility issues and personal reasons. For example,
individuals residing in remote or isolated areas may be difficult to access. The Aborigine
population is an instance of an unvaccinated community due to this reasoning. Alternately,
legislation mandating vaccinations could also ostracize individuals concerned that vaccines are
non-Halal. Malaysia is a majority Muslim country, and no vaccine has been fully certified as
Halal by the country’s Islamic council. Alternate propositions include the creation of a
computerized vaccination registry, the vaccination of children of migrants, and the
implementation of supplementary immunization activity. While these interventions may mitigate
the rise in VPDs, they may not combat the country-specific causes behind vaccine hesitancy
(Wong et al., 2020).
Ultimately, this case study reveals the potential risk vaccine hesitancy poses to overall
society. Currently, the Malaysian government and health professionals are faced with difficult
decisions in combatting the rise in vaccine hesitancy and the increased prevalence of VPDs.
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However, in a context-specific setting, the rise in Malaysian VPDs reveals the cultural nuances
that drive vaccine hesitancy and ultimately contribute to the receptiveness of interventions.

Efforts to Increase Vaccine Uptake
As demonstrated in the Malaysian case study, mitigation efforts for vaccine hesitancy
must regard contextual and cultural variances within the targeted country. No evidence-based
approach exists that is universal. Historically, some interventions have backfired and, ultimately,
strengthened hesitancy and resistance. As such, efforts to increase vaccine acceptance must be
carefully considered before implementation (R. M. Jacobson et al., 2015).
The United States and Luxembourg are two countries in which vaccinations are typically
administered in medical facilities, as opposed to schools or work offices. Evidently, the
educational efforts utilized in this system (e.g., within waiting rooms, brochures, and public
service announcements) have proven ineffective. Furthermore, maintaining vaccinations within
doctors’ offices limits accessibility to those who adhere to routine checkups. In the United States,
insurance coverage is also a significant barrier. In such instances, expanding vaccination
accessibility to public and well-trafficked areas, such as schools and work offices, may increase
vaccine uptake (R. Jacobson, personal communication, April 26, 2022).
Confusing recommendations may also contribute to vaccine hesitancy. The language
utilized in encouraging vaccinations often poses it as a choice. As such, individuals are more
inclined to question the recommendation, as it lacks clarity. For example, when a health
professional announces, “You are due for …” it equates to a strong recommendation.
Alternately, statements, such as “What are your thoughts on…” are weak, as they make a
negative response reasonable (R. Jacobson, personal communication, April 26, 2022). While the
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latter offers an opportunity for communication, the lack of assurance from a seemingly reputable
source is concerning and may create additional hesitancy. Furthermore, multiple studies have
demonstrated presumptive, as opposed to participatory, approaches to provider-parent vaccine
conversations are the most effective approach for vaccine acceptance (McClure et al., 2017).
Extensive research demonstrates the role that language plays in vaccine hesitancy. While
deliberate word choice or phrasing can decrease hesitancy, the presentation of information in
foreign languages may also make an impact. For bilingual individuals, one language may be
associated with greater public trust. Subsequently, even if the information received is equivocal,
the perception of it may be changed. Communication, which essentially is the manner in which
information is transmitted and obtained, is a critical aspect of increasing trust and reducing
vaccine hesitancy (Witynski, 2022).
Since no clear strategy to combat hesitancy exists, perhaps the transmission of knowledge
among those involved in the administration of immunization is of the most important
interventions. The causes and prevalence of vaccine hesitancy are context-specific. Therefore,
health care providers and those associated with immunization programs must know how to
properly identify and address them (Dubé et al., 2014). At a population level, notions such as
transparency in vaccine policy and equipping vaccination administrators with the necessary tools
to properly communicate with vaccine-hesitant individuals may also aid in increasing the overall
vaccine uptake (Dubé et al., 2013). Nevertheless, this aspect of vaccine hesitancy requires further
research and experimentation to uncover effective mitigation strategies.
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Contribution of Increased Privilege to Vaccine Hesitancy
Low vaccine uptake is not necessarily strongly correlated to the inaccessibility,
unavailability, or abundance of immunizations. According to Larson et al. (2016), “Countries
with the highest levels of schooling and good access to health services are associated with lower
rates of positive sentiment, pointing to an emerging inverse relationship between vaccine
sentiments and socio-economic status.”
Studies in high-income countries are showing trends in which vaccine hesitancy is most
prevalent among individuals who are in the upper-middle class and highly educated (Swiss TPH,
2021). Furthermore, the most highly educated individuals (Masters/Ph.D.) report similar
sentiment regarding vaccine importance to those with little-to-no education. As such, vaccine
hesitancy cannot reflect minimal knowledge or health literacy (Larson et al., 2016).
Immunization managers, who are responsible for overseeing immunization programs at state and
national levels, tended to agree that non-compliant individuals were of high education levels,
well-informed, and interested in health-related issues. This observation was obtained during a
global study, revealing that this association is not limited to a specific geographic region (Dubé
et al., 2014).

Case Study: Southeastern France
France is an interesting case study, particularly given the high skepticism of vaccine
safety. Perhaps some of the hesitancy is correlated with French vaccine scares within the past
few decades. For example, during the 1990s, media reports advertised a link between hepatitis B
vaccination and multiple sclerosis. In addition to the hepatitis B immunization, the H1N1, HPV,
and DTP vaccinations have been the rhetoric of controversy in France. According to the French
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official immunization schedule, all children should be vaccinated against eleven diseases
(Peretti-Watel et al., 2019).
In 2014, Peretti-Watel et al. conducted a comparative, interview-based study in
Southeastern France. This research sought to identify the variances in child vaccination
sentiment among individuals of varying socio-demographic statuses. Participants, who were
parents of young children, were recruited through two nursery schools to interview for this study.
These schools were selected given the drastic socio-demographic variances between their
communities. The Gooseberry School was a poor, suburban public school, with many students
coming from single-parent, unemployed, and migrant households. Alternately, Blackberry
School was a downtown-based, private school located in a more affluent area. This study
included 25 interviews, twelve of whom were mothers from the Gooseberry School and thirteen
of whom were parents from Blackberry School (eleven mothers and two fathers). While this
study is not necessarily reflective of all French parents’ positions regarding vaccine hesitancy, it
has the potential to evaluate the role that privilege may play. Furthermore, at the time the
interviews were conducted, the French official immunization schedule mandated vaccination
against three diseases (diphtheria, tetanus, and polio), while eight additional were recommended
(measles, mumps, rubella, Haemophilus influenzae, hepatitis B, pertussis, pneumococcus, and
meningococcus). In 2018, vaccination for all eleven of these diseases became mandatory
(Peretti-Watel et al., 2019).
As demonstrated in Table 1, the participants whose children attended Gooseberry School
consistently had higher vaccination rates than their Blackberry School counterparts. While all the
children at Gooseberry School were vaccinated against DTP and MMR, only nine and ten from
Blackberry School were vaccinated, respectively. Furthermore, the vaccination rate against

VACCINE HESITANCY AND PRIVILEGE

20

hepatitis B is stark, with 83.3% and 46.2% of students immunized at Gooseberry School and
Blackberry School, respectively. Gooseberry School’s protection against hepatitis B is nearly
double that of Blackberry School, both from a percentage and numerical standpoint (PerettiWatel et al., 2019).

Table 1. Study results from 2014 reveal a potential correlation between school enrollment, parents' educational achievement,
and child's immunization status (Peretti-Watel et al., 2019)

Gooseberry School

Blackberry School

< High school

13/20

0/24

High school

4/20

1/24

> High school

3/20

23/24

DTP (mandatory)

12/12

9/13

MMR

12/12

10/13

Hepatitis B

10/12

6/13

Meningococcus

8/12

7/13

Parents’ educational level

Child’s immunization status

Despite the discrepant immunization rates, many parents – from both schools – expressed
doubts and hesitancy toward specific vaccinations. Very few of the participants’ children had
received all required and recommended vaccines and many reported delayed vaccinations.
Parents who lived through the controversial hepatitis B vaccination campaign during the late
twentieth century reported their personal experiences impacted their decision not to vaccinate
their children against hepatitis B. Many of the causes of vaccine hesitancy were similar between
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the two groups of participants: personal experience and fear of side effects. However,
participants with children attending the more affluent Blackberry School also regarded the
necessity for vaccinations, along with their invasive and unnatural nature. Comparatively, the
parents from the Gooseberry School appeared to know little of specific vaccines, beyond their
names (Peretti-Watel et al., 2019).
Though the two groups possessed similarly hesitant sentiments regarding vaccinations, it
is evident that fewer vaccinations were administered to participants’ children at the Blackberry
School. While there is no apparent reasoning for this trend, it is possible that participants at
Gooseberry School were more likely to vaccinate their children despite enduring doubts and
hesitancy. Social pressure can contribute to a parent’s decision to vaccinate their child. For
example, doctors and nurses, who are viewed as trustworthy professionals, may urge parents to
vaccinate their children. Additionally, Western ideals may label parents as “bad” through their
rejection of perceived health-promoting activities for their children (Deml et al., 2022).
Subsequently, parents may make vaccination decisions to avoid judgment or unsolicited input,
rather than following their personal beliefs. Furthermore, these discrepancies may correlate with
the degree of privilege possessed by the participants:
Parents with a higher socioeconomic status were able to engage more resources and use a
wider repertoire of actions, and they also displayed greater health literacy. From this
perspective, vaccine hesitancy illustrates how “the sphere of responsible mothering”
expands, and how mothers who lack money, time and other resources struggle to conform
to contemporary risk culture. (Peretti-Watel et al., 2019)
Since the more affluent parents addressed vaccine hesitancy with greater resources, such as fully
developed knowledge of the topic matter and increased financial flexibility, perhaps their
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arguments were met with more reverence and credibility. Alternately, privileged families may be
able to select a health care provider based on their beliefs and trust, as opposed to the most costeffective option or insurance coverage (Deml et al., 2022). Nevertheless, this case study of two
Southeastern French nursery schools reveals evidence of a potential negative correlation between
privilege and vaccine acceptance. However, it continues to pose a question regarding the
association of vaccine hesitancy with privilege because the parents from both schools relayed
similar sentiments of skepticism.

Case Study: Australia
The correlation between privilege and vaccine hesitancy has been explored in various
Australian regions. Extensive research has mapped out vaccination coverage and identified
regional vaccination trends and patterns. Within the country, under-immunization and VPD
outbreaks appear to cluster geographically. The Australian national aspirational coverage target
for VPD immunity has been set to 95% by the government. Though significant strides in
immunization coverage have been made, clusters of low vaccination rates and vaccine resistance
are impeding the attainability of this goal. Logistical and accessibility issues contribute, to an
extent, to lowered vaccination rates. However, of greater concern are the increasing number of
those who are vaccine-hesitant or refusing (Bryden et al., 2019).
Utilizing the 2016 Australian Census of Population and Housing, Bryden et al. (2019)
conducted an ecological study, analyzing the overlay of communal-level vaccination data with
socio-demographic variables. As demonstrated in Table 2, the data provide evidence that
postcodes with lower vaccination rates had a high classification of privilege (as demonstrated by
completion of post-secondary education, high weekly incomes, and white-collar jobs – except for
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the unemployment indicator). In a general, purely data-based sense, postcodes with relatively
greater privilege demonstrated a great inclination away from vaccination, while those that were
relatively more disadvantaged demonstrated higher vaccination rates. Given the format of this
study, inferences cannot be made regarding individual behavior making regarding vaccination.
Subsequently, the data provided offers a reflection of general, group applicable trends. As such,
information regarding the direct drivers of vaccination is unavailable (Bryden et al., 2019).

Table 2. Relevant area-based socio-demographic variables for, on average, more of the target population (Bryden et al., 2019).

Postcodes with Lower Vaccination Rates

Postcodes with Higher Vaccination Rates

With a bachelor’s degree level or higher as their

Having only completed year 10, 11, or 12 as their

highest level of education;

highest level of education;

Being unemployed; having an occupation as a

With an occupation as a technician or trade

manager, professional;

worker, community and personal service worker,
clerical and administrative worker, sales worker,
machinery operator and driver, laborer;

With a weekly income of $2000-3000; with a very

With a lower personal weekly income (<$1000;

high personal weekly income ($3000 and over).

and $1000-2000).

To identify potential reasons for vaccine hesitancy among individuals with higher SES,
Swaney & Burns (2019) conducted interviews with parents (eleven) and health care providers
(seven) in Perth, Australia in 2017. Participation inclusion was based on an annual gross
combined income greater than $125,000 AUD. Given the small sample size and qualitative
nature of this research, the results are not representative of all Perth residents, nor are they an
accurate depiction of all individuals of high SES (Swaney & Burns, 2019).

VACCINE HESITANCY AND PRIVILEGE

24

Similar sentiments expressed throughout the interviews were categorized in a theoretical
model with four themes: education, health control, vaccine risk, and trust. Parents expressed
beliefs that their higher education enhanced their health literacy and ability to make sound,
logical medical-related decisions. Another expressed explanation lay within an individual’s
ability to control their health. Healthism, which is this notion that prioritizes individual health,
largely disregards social responsibility and herd immunity. As such, vaccinations are viewed
solely through a self-centric lens, instead of acknowledging the role of the community in disease
prevention and spread. Furthermore, interviewees portrayed a low perception of risk “because
they live in Australia, and in particular, Perth,” (Swaney & Burns, 2019). Subsequently, greater
fear was demonstrated for vaccine side effects than VPD infection. Finally, the parents displayed
mistrust in the information they receive regarding vaccination. Instead, they desired information
that was more personalized and emotive. However, despite expressing these sentiments
regarding ineffective information, the interviewees remained steadfast in their ability to make the
best vaccination decisions for their children (Swaney & Burns, 2019). This research ultimately
reveals potential drivers behind lowered vaccination rates in Perth, Australia, and perhaps
contributes to the country’s difficulty in achieving its vaccination coverage goal.

Privilege as a Confounding Variable
Both income and education have frequently been identified as significant determinants of
vaccine hesitancy. Privilege has been demonstrated to have an inverse relationship with vaccine
acceptance. However, often simultaneously, the relationship is positive. “Vaccine hesitancy
determinants like education and socio-economic status do not influence hesitancy in only one
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direction” (MacDonald, 2015). Strictly speaking, vaccine hesitancy is evidently caused by
income and educational attainment, both high and low.
In a systematic review of published literature between 2007 and 2012, Larson et al.
uncovered both levels of income and education to be influential determinants of vaccine
hesitancy. Of the 76 included studies, eight and six regarded income and education, respectively.
Furthermore, these were two of the three contextual influences mentioned in the systematic
review (the third being communication and media environment). Nevertheless, the results
associated with both education and income were inconsistent. In China, Lebanon, and Israel
higher education was presented as an indication of vaccine hesitancy. Alternately, in Greece, The
Netherlands, and Pakistan it was viewed as a promoter of vaccination. While literature varied
between countries, contradictory results were produced within a given country, too. For example,
two included studies from the United States revealed conflicting evidence, as one suggested high
SES as a barrier to vaccination, while the other low SES. Despite the evidence available for the
extremes of the continuum of income, middle-level income was identified as a non-significant
influence on vaccine hesitancy (Larson et al., 2014).
Given the discrepant representations of privilege as a factor of vaccine hesitancy, perhaps
it must be considered an independent or confounding variable. According to Larson et al., “The
reasons why these factors were influential are not always explained, and when they are, other
influencing factors are usually cited” (2014). Subsequently, these aspects of privilege cannot be
considered in isolation. As such, perhaps privilege does not directly impact vaccine hesitancy,
instead only bolstering the true determinants.
Beyond privilege, many other factors may influence and drive vaccine hesitancy. From a
psychological standpoint, vaccine hesitancy considers aspects of risk-taking. For example, risk-
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taking is elevated among young men. Therefore, regions with greater proportions of young men
may experience heightened levels of vaccine hesitancy (M. Browne, personal communication,
April 20, 2022). More contemporarily, political viewpoints have also contributed to vaccine
resistance. In the United States, especially regarding the COVID-19 vaccine, vaccine hesitancy
and anti-vaccination sentiment have closely aligned with political beliefs and party alignment.
Alternately, vaccine hesitancy is an individualistic notion, particularly given the reliance
upon herd immunity for protection. As such, the individualistic or collectivist nature of a specific
country may also impact the prevalence of vaccine hesitancy (M. Browne, personal
communication, April 20, 2022). In independent societies, decision-making can, to a degree, be
callous. Healthy individuals without increased morbidity who choose not to vaccinate are not
necessarily putting themselves in danger. However, there is a lack of regard for communal
responsibility (R. Jacobson, personal communication, April 26, 2022). Healthism is another
prominent cause of vaccine hesitancy, as demonstrated in the Australian case study, particularly
in individualistic settings. Individuals adhering to healthism saturate themselves in health
information and execute the best health practices. Subsequently, these parents prefer to evaluate
the safety and risk of vaccines through their attainment of information, often appearing more
hesitant. Since healthism tends to incorporate the natural attainment of immunity, such as that
through breastfeeding, practicing parents may also seek alternative medicines in lieu of routine
vaccinations (SwissTPH, 2021).

Conclusion
Vaccine hesitancy is a complex, multi-faceted public health concern. Though undervaccination is not a new phenomenon, it threatens to reintroduce successfully eliminated VPDs.
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Despite low-risk perceptions associated with VPDs, their reemergence can create dire
circumstances, particularly in poorer regions. Given the disproportionate impact of reduced
vaccine acceptance, the question of the degree to which privilege, which has been defined as
high educational levels and SES, contributes to vaccine-hesitant sentiment arises. While high
levels of privilege do indeed correlate to vaccine hesitancy, so too do low levels of privilege.
Therefore, while some relationship between the two factors is evident, there is not necessarily
enough evidence to identify privilege as causal.
Even before Edward Jenner’s revolutionary smallpox inoculation, skepticism and outright
rejection of this preventative measure were apparent. The history of vaccinations, and the
concurrent development and strengthening of anti-vaccination movements, remain relevant in
understanding the motivations behind and considerations of vaccine hesitancy. Initial critics of
vaccinations were wary of the efficacy and science behind them. Andrew Wakefield’s falsified
publication in The Lancet is perhaps the landmark argument against vaccinations. Though the
link between the MMR vaccine and autism has been discredited, many continue to question the
safety of vaccinations.
Today, vaccine hesitancy appears across the world. As its presence has continued to
increase, under-vaccination has become of dire concern. VPDs are reappearing in countries and
regions where they had previously been eradicated. Given the unfamiliarity with some VPDs,
individuals miscalculate the true risk they pose. Subsequently, VPDs will be returning to places
that are ill-equipped to manage the fallout. Thus far, the weakening of herd immunity and VPD
outbreaks, along with subsequently increased mortalities have been attributed to vaccine
hesitancy. Though vaccine hesitancy appears universally, it is influenced by many nuanced
factors. As such, no simple evidence-based solution exists to mitigate skepticism toward
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vaccinations. Future directions for research should consider mitigation strategies, both
universally and in context-specific settings.
In many instances, the completion of post-secondary education (either at a bachelor’s or
graduate level) and high income have been tied to the heightened prevalence of vaccine
hesitancy. This trend is particularly evident in case studies of Southeastern France and Australia.
Alternately, low SES and incomplete education have also been demonstrated to be a barrier to
vaccination acceptance. Given the inconsistent role that privilege (or lack thereof) plays in
vaccine hesitancy, some may argue against any relationship between the two. Furthermore, other
factors, such as political polarization, the individualistic nature of a country, and risk-taking, may
ultimately contribute to decisions regarding vaccinations and may prove worthy of future
research.
In free countries, everyone possesses the ability to make independent decisions regarding
any public health matter. While vaccination is one example, practices such as smoking cigarettes
and seat belt use are also personal preferences. Nevertheless, these choices ultimately have a
collective impact. Vaccination is simply one of many preventative public health interventions
that are viewed controversially. Clear reasoning exists to explain why individuals opt in or out of
specific interventions. However, the upstream factors, including privilege, which influence these
decisions are less evident. Though this study may fail to support a defined causal relationship
between privilege and vaccine hesitancy, it provides ample evidence to suggest the existence of
some connection between the two. In instances of both low and high prevalence, the notion of
privilege tends to produce heightened rates of vaccine hesitancy. Perhaps the future direction of
this research may explore why the two extremes of privilege impact vaccine hesitancy in an
opposite manner than its neutral counterpart.
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List of Abbreviations
Abbreviation

Explanation

DTP

Diphtheria, Tetanus, and Pertussis

MMR

Measles, Mumps, and Rubella

SAGE

Strategic Advisory Group of Experts on
Immunization (WHO)

SDH

Social determinants of health

VPD

Vaccine-preventable disease

WG

Working Group on Vaccine Hesitancy
(SAGE)

WHO

World Health Organization
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